Business Wire

UNIVERSITY-OF-OULU

30.6.2020 06:07:12 CEST | Business Wire | Press release

Share
University of Oulu: Butterfly Wings As Inspiration for More Effective Solar Panels

The color of butterflies is mainly attributed to structural color as a result of diffraction of natural light. However, black color denotes trapping of sunlight within the butterfly scales. In some extreme cases, a butterfly will be rapidly de-iced through light-heat conversion within black scales on wings. Inspired by such a natural light harvesting process, scientists in the University of Oulu, Finland, research unit NANOMO carefully examined nanostructures of black scales obtained from different butterflies and assessed their light trapping abilities when placed on Si-based solar panels.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200629005043/en/

Even with apparently the same dark color, butterfly scales have varied nanostructures depending on their species. For example, the morphology of Ornithoptera priamus scale consists of parallel V-shaped gullies formed between two ridges and connected by thin layers. This is very different from the scale structure of other three species, Tirumala limniace, Graphium doson, and Papilio protenor cramer, where the structures consist of round ridges spaced by arrays of 1, 2, and 3 holes. Correspondingly, light reflection on the black scales differs, with the one on the black part of Ornithoptera priamus owing minimum values ranging from 1-5% at the visible light region.

Using these structures as antireflective patterns will help sunlight harvesting on Si based photovoltaics. Computer simulated results showed that after placing these nanostructures on Si solar panels, surface backscattering decreased substantially. The scale structure of Ornithoptera priamus gave the best antireflection. Light reflection decreased from more than 35% on bare Si panel down to less than 5%. As a result, the short-circuit current, i.e. the largest current that can be obtained from the photovoltaic cell, was increased by 66%. Experimental realizations of such a strategy have also been proposed.

The latest research progress continues the world-leading role of NANOMO group in biomimicry. The unit pioneers in applying fundamental concepts in physics to applied photonics and solar energy harvesting. The research was coordinated by Professors Wei Cao and Marko Huttula, University of Oulu.

Considering the large volume of Si solar panels in use, it is foreseen that the butterfly wings can provide a major contribution to clean energy production.

Article:
Zhongjia Huang, Xinying Shi, Gang Wang, Petri Leukkunen, Marko Huttula, Wei Cao:
Antireflective design of Si-based photovoltaics via biomimicking structures on black butterfly scales, Solar Energy, Volume 4. DOI: https://doi.org/10.1016/j.solener.2020.05.031 sciencedirect.com 2020
https://www.sciencedirect.com/science/article/pii/S0038092X2030520X

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release

- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur

Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release

Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i

Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release

Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different

Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release

A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye